1
|
Lang P, Seslija P, Chu MWA, Bainbridge D, Guiraudon GM, Jones DL, Peters TM. US–Fluoroscopy Registration for Transcatheter Aortic Valve Implantation. IEEE Trans Biomed Eng 2012; 59:1444-53. [DOI: 10.1109/tbme.2012.2189392] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
2
|
Guiraudon GM. [The role of antiarrhythmic surgery in 2004]. Arch Mal Coeur Vaiss 2004; 97:1130-4. [PMID: 15609916] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
In 2004, surgery for cardiac arrhythmias addresses essentially atrial fibrillation. Surgery is only a rare alternative for other cardiac arrhythmias in center that still have the surgical skill. Surgery for atrial fibrillation has the definite advantage of concomitant exclusion of the left atrial appendage which is the predominant site of intra-atrial thrombi with the associated risk of severe thrombo-embolic events. Our experience with surgery for lone atrial fibrillation, using the Corridor III operation, shows that surgery is associated with high efficacy and long term control of arrhythmia when the surgical technique is well performed. Failures were associated with incomplete line of block or exclusion. This experience shows the necessity of postoperative EP testing. Initially performed using open heart technique, surger for atrial fibrillation is now performed using mini-invasive technique. Indications for surgery for lone atrial fibrillation will decreased while other strategies are developing. To remain competitive surgery must have high efficacy and use mini-invasive techniques. i.e.: closed off pump beating heart via port access. Surgery for atrial fibrillation concomitant with other cardiac surgical repairs yields remarkable results, without increased surgical risk. Their indications go beyond mitral valve pathology. Future developments imply the following conditions: atrial surgery must not increase morbidity, and its cost-effectiveness must be documented. Combined surgery must be testable and tested to gain valid pathophysiological data to improve surgical rationales. Its impact in terms of survival, prevention of thrombo-embolic events and quality of life will be documented by clinical trials.
Collapse
Affiliation(s)
- G M Guiraudon
- The Robarts Research Institute, University of Western Ontario, London, Canada.
| |
Collapse
|
3
|
Hendry PJ, Mussivand TV, Masters RG, Bourke ME, Guiraudon GM, Holmes KS, Day KD, Keon WJ. The HeartSaver left ventricular assist device: an update. Ann Thorac Surg 2001; 71:S166-70; discussion S183-4. [PMID: 11265854 DOI: 10.1016/s0003-4975(00)02613-8] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
BACKGROUND Ventricular assist devices have been shown to be effective as bridges to transplantation and recovery for patients with end-stage heart failure. Current technology has been limited because of the need for percutaneous connections with controllers. The HeartSaver ventricular assist device (VAD) (World Heart Corporation, Ottawa, Ontario, Canada) was developed with the intention of having a completely implantable, portable VAD system. The system consists of an electrohydraulic blood pump, internal and external battery power, and a transcutaneous energy transfer and telemetry unit that allows for power transmission through the skin. Control of the device may be achieved locally or remotely through a variety of communication systems. METHODS The device has been modified with the Series II preclinical version being available for in vitro (mock loop) and in vivo (bovine model) testing. RESULTS Seventeen Series II devices have been functional on mock loops or other testing trials for an accumulated 900 days of operation. There have been eight acute experiments using a bovine model to test various components as they have become available from manufacturing. Mean pump output was 10.4 +/- 1.1 L/min in full-fill/full-eject mode. Changes in the last 24 months include (1) cannula redesign for better port alignment and integration of tissue valves; (2) battery redesign to convert to new lithium-ion cells; (3) optimized infrared information and electromagnetic inductance energy transmission through various skin thicknesses and pigmentation; and (4) improved reliability of internal and external controller hardware and software. CONCLUSIONS Modifications have been required to optimize the HeartSaver VAD's performance. The final HeartSaver VAD design will be produced in the near future to allow for formal in vitro and in vivo testing before clinical implantation.
Collapse
Affiliation(s)
- P J Hendry
- Division of Cardiac Surgery, University of Ottawa Heart Institute, Ontario, Canada
| | | | | | | | | | | | | | | |
Collapse
|
4
|
Abstract
This report describes a 33-year-old patient with arrhythmogenic right ventricular (RV) dysplasia who had a dual chamber pacemaker implanted at age 23 years for drug-induced bradycardia. Pacing was continued after right ventricular free-wall disconnection (RVFWD) at age 24 years. Her pacemaker was not replaced after battery depletion 7 years later. She presented the following year in severe right-sided heart failure. Her old pacemaker generator was replaced. This was followed by rapid resolution of her clinical failure and return to a full, active, physical lifestyle. This observation suggests the potential benefit of dual chamber pacing in patients with RV dysplasia after RVFWD.
Collapse
Affiliation(s)
- C Tang
- Department of Medicine, University of British Columbia, Vancouver, Canada
| | | | | | | | | | | |
Collapse
|
5
|
Cosío FG, Anderson RH, Kuck KH, Becker A, Borggrefe M, Campbell RW, Gaita F, Guiraudon GM, Haïssaguerre M, Rufilanchas JJ, Thiene G, Wellens HJ, Langberg J, Benditt DG, Bharati S, Klein G, Marchlinski F, Saksena S. Living anatomy of the atrioventricular junctions. A guide to electrophysiologic mapping. A Consensus Statement from the Cardiac Nomenclature Study Group, Working Group of Arrhythmias, European Society of Cardiology, and the Task Force on Cardiac Nomenclature from NASPE. Circulation 1999; 100:e31-7. [PMID: 10430823 DOI: 10.1161/01.cir.100.5.e31] [Citation(s) in RCA: 112] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Current nomenclature for the atrioventricular (AV) junctions derives from a surgically distorted view, placing the valvar rings and the triangle of Koch in a single plane with antero-posterior and right-left lateral coordinates. Within this convention, the aorta is considered to occupy an anterior position, although the mouth of the coronary sinus is shown as being posterior. Although this nomenclature has served its purpose for the description and treatment of arrhythmias dependent on accessory pathways and atrioventricular nodal reentry, it is less than satisfactory for the description of atrial and ventricular mapping. To correct these deficiencies, a consensus document has been prepared by experts from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. It proposes a new anatomically sound nomenclature that will be applicable to all chambers of the heart. In this report, we discuss its value for description of the AV junctions, establishing the principles of this new nomenclature.
Collapse
Affiliation(s)
- F G Cosío
- Cardiology Service, Hospital Universitario de Getafe, Carretera de Toledo, km 12,5, 28905 Getafe, Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Cosío FG, Anderson RH, Becker A, Borggrefe M, Campbell RW, Gaita F, Guiraudon GM, Haïssaguerre M, Kuck KJ, Rufilanchas JJ, Thiene G, Wellens HJ, Langberg J, Benditt DG, Bharati S, Klein G, Marchlinski F, Saksena S. Living anatomy of the atrioventricular junctions. A guide to electrophysiological mapping. A Consensus Statement from the Cardiac Nomenclature Study Group, Working Group of Arrythmias, European Society of Cardiology, and the Task Force on Cardiac Nomenclature from NASPE. North American Society of Pacing and Electrophysiology. Eur Heart J 1999; 20:1068-75. [PMID: 10413636 DOI: 10.1053/euhj.1999.1657] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
Current nomenclature for atrioventricular junctions derives from a surgically distorted view, placing the valvar rings and the triangle of Koch in a single plane with antero-posterior and right-left lateral coordinates. Within this convention, the aorta is considered to occupy an anterior position, while the mouth of the coronary sinus is shown as being posterior. While this nomenclature has served its purpose for the description and treatment of arrhythmias dependent on accessory pathways and atrioventricular nodal re-entry, it is less than satisfactory for the description of atrial and ventricular mapping. To correct these deficiencies, a consensus document has been prepared by experts from the Working Group of Arrhythmias of the European Society of Cardiology, and the North American Society of Pacing and Electrophysiology. It proposes a new, anatomically sound, nomenclature that will be applicable to all chambers of the heart. In this report, we discuss its value as regards the description of the atrioventricular junctions, establishing the principles of this new nomenclature.
Collapse
Affiliation(s)
- F G Cosío
- Hospital Universitario de Getafe, Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Cosío FG, Anderson RH, Kuck KH, Becker A, Benditt DG, Bharati S, Borggrefe M, Campbell RW, Gaita F, Guiraudon GM, Haïssaguerre M, Klein G, Langberg J, Marchlinski F, Rufilanchas JJ, Saksena S, Thiene G, Wellens HJ. ESCWGA/NASPE/P experts consensus statement: living anatomy of the atrioventricular junctions. A guide to electrophysiologic mapping. Working Group of Arrhythmias of the European Society of Cardiology. North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol 1999; 10:1162-70. [PMID: 10466499 DOI: 10.1111/j.1540-8167.1999.tb00291.x] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Current nomenclature for the AV junctions derives from a surgically distorted view, placing the valvar rings and the triangle of Koch in a single plane with anteroposterior and right-left lateral coordinates. Within this convention, the aorta is considered to occupy an anterior position, whereas the mouth of the coronary sinus is shown as being posterior. Although this nomenclature has served its purpose for the description and treatment of arrhythmias dependent on accessory pathways and AV nodal reentry, it is less than satisfactory for the description of atrial and ventricular mapping. To correct these deficiencies, a consensus document has been prepared by experts from the Working Group of Arrhythmias of the European Society of Cardiology and from the North American Society of Pacing and Electrophysiology. It proposes a new, anatomically sound, nomenclature that will be applicable to all chambers of the heart. In this report, we discuss its value for description of the AV junctions and establish the principles of this new nomenclature.
Collapse
Affiliation(s)
- F G Cosío
- Cardiology Service, Hospital Universitario de Getafe, Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Kimman GP, van Hemel NM, Jessurun ER, van Dessel PF, Kelder JC, Defauw JJ, Guiraudon GM. Comparison of late results of surgical or radiofrequency catheter modification of the atrioventricular node for atrioventricular nodal reentrant tachycardia. Eur Heart J 1999; 20:527-34. [PMID: 10365289 DOI: 10.1053/euhj.1998.1337] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
AIMS Although arrhythmia surgery and radiofrequency catheter ablation to cure atrioventricular nodal reentrant tachycardia differ in technical concept, the late results of both methods, in terms of elimination of the arrhythmogenic substrate and procedure-related new and different arrhythmias, have never been compared. This constituted the purpose of this prospective follow-up study. METHODS AND RESULTS Between 1988 and 1992, 26 patients were surgically treated using perinodal dissection or 'skeletonization', and from 1991 up to 1995, 120 patients underwent radiofrequency modification of the atrioventricular node for atrioventricular nodal reentrant tachycardia. The acute success rates of surgery and radiofrequency catheter ablation were 96% and 92%, respectively. Late recurrence, rate in the surgical and radiofrequency catheter ablation groups was 12% and 17%, respectively. Mean follow-up was 53 months in the surgical group and 28 months in the radiofrequency catheter ablation group. The final success rate after repeat intervention was 100% in the surgical group and 98% in the radiofrequency catheter ablation group. Comparison of the initial and recent series of radiofrequency catheter ablated patients showed an increased initial success rate with fewer applications. In the radiofrequency catheter ablation group, a second- or third-degree block developed in three patients (2%), requiring permanent pacing, whereas in the surgical group no complete atrioventricular block was observed. Inappropriate sinus tachycardia needing drug treatment was observed in 13 patients (11%), mostly after fast pathway ablation, but was never observed after surgery. New and different supraventricular tachyarrhythmias arose in 27% of the patients in the surgical group and in 11% of the radiofrequency catheter ablation group, but did not clearly differ. CONCLUSION This one-institutional follow-up study demonstrated comparable initial and late success rates as well as incidence of new and different supraventricular arrhythmias following arrhythmia surgery and radiofrequency catheter ablation for atrioventricular nodal reentrant tachycardia. Today radiofrequency catheter ablation has replaced arrhythmia surgery for various reasons, but the late arrhythmic side-effects warrant refinement of technique.
Collapse
Affiliation(s)
- G P Kimman
- Department of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands
| | | | | | | | | | | | | |
Collapse
|
9
|
Abstract
Cardiac surgeons took to the heart and claimed an exclusive privilege to intervene. The task of cardiologists was to identify "candidates" and feed the Great Surgical Machine. Recently catheter surgery has developed and fell into the hands of cardiologists, who became interventionists. Cardiac surgeons are concerned about losing interventions and their identify. The analysis of the current situation implies a revisitation of old concepts: surgery, intervention, therapy, patients, invasiveness etc ... etc ... and a review of our therapeutic philosophy. Therapeutic plans comprise three interrelated components: the target, the bullet (therapeutic agent), and the gun (the way of delivering the bullet on target). This description characterizes surgery as a way of delivering. If side effects are effects that do not affect the target, surgical procedures are mostly side effects, with significant morbidity. Future surgical rationales should reconcile target-specific therapy and minimal collateral damages: Minimal Surgery! or to use a new buzz, less invasiveness. Cardiac surgery has focused too much on surgical practice and neglected the rest of cardiology, missing opportunities for new researches, new rationales, and new techniques. Surgeons must become again Renaissance Men, involved in the entire field of cardiology, with a special skill in surgical techniques. Cardiac surgeons should no longer confine their practice to the delivering end. This end does not, any more, justify the means.
Collapse
Affiliation(s)
- G M Guiraudon
- CGF-Millard Fillmore Division, Department of Thoracic and Cardiovascular Surgery, Buffalo, New York 14209, USA.
| |
Collapse
|
10
|
Abstract
Cardiac surgeons took to the heart and claimed an exclusive privilege to intervene. The task of cardiologists was to identify "candidates" and feed the great surgical machine. Recently, catheter surgery was developed and has fallen into the hands of cardiologists who became interventionists. Cardiac surgeons are concerned about shrinking domain, identity, and the future. The analysis of the current situation requires another look at old concepts: surgery, intervention, therapy, patients, invasiveness, etc., and a revision of the philosophy of the entire profession. Therapeutic plans comprise three interrelated components: the target, the bullet (therapeutic agent), and the gun (the way of delivering the bullet on target ). This description characterizes surgery as a way of delivering. If side effects are effects that do not affect the target, surgical procedures are mostly side effects, with significant morbidity. Future surgical rationales should reconcile target-specific therapy and minimal collateral damages: "minimal surgery!" or to use a new buzzword, "less invasive surgery." Cardiac surgery has focused on surgical practice and neglected the science of cardiology, missing opportunities for new research, new rationales, new techniques, and new territories. Surgeons must again become Renaissance men, involved in the entire field of cardiology, with a special skill in surgical techniques. Cardiac surgeons should no longer confine their practice to the delivering end. This end does not, any more, justify the means.
Collapse
Affiliation(s)
- G M Guiraudon
- The CGF-Millard Fillmore Division, Department of Thoracic and Cardiovascular Surgery, Buffalo, New York 14209, USA.
| |
Collapse
|
11
|
Darrah WC, Sharpe MD, Guiraudon GM, Neal A. Intraaortic balloon counterpulsation improves right ventricular failure resulting from pressure overload. Ann Thorac Surg 1997; 64:1718-23; discussion 1723-4. [PMID: 9436561 DOI: 10.1016/s0003-4975(97)01102-8] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
BACKGROUND Right ventricular (RV) dysfunction is common after heart transplantation, and myocardial ischemia is considered to be a significant contributor. We studied whether intraaortic balloon counterpulsation would improve cardiac function using a model of acute RV pressure overload. METHODS In 10 anesthetized sheep, RV failure was induced using a pulmonary artery constrictor. Baseline measurements included mean systemic blood pressure, RV peak systolic pressure, cardiac index, and RV ejection fraction. Myocardial and organ perfusion were measured using radioactive microspheres. RESULTS After pulmonary artery constriction, there was an increase in RV peak systolic pressure (32 +/- 2 to 60 +/- 3 mm Hg; p < 0.01) and a decrease in mean systemic blood pressure (68 +/- 4 to 49 +/- 2 mm Hg; p < 0.01), RV ejection fraction (0.51 +/- 0.04 to 0.16 +/- 0.02; p < 0.01), and cardiac index (2.48 +/- 0.04 to 1.02 +/- 0.11; p < 0.01). Blood flow to the RV did not change significantly, but there was a significant reduction in blood flow to the left ventricle. The initiation of intraaortic balloon counterpulsation (1:1) using a 40-mL intraaortic balloon inserted through the left femoral artery resulted in an increase in mean systemic blood pressure (49 +/- 2 to 61 +/- 3 mm Hg; p < 0.01), cardiac index (1.02 +/- 0.11 to 1.45 +/- 0.14; p < 0.05), RV ejection fraction (0.16 +/- 0.02 to 0.23 +/- 0.02; p < 0.01), and blood flow to the left ventricle. CONCLUSIONS In a model of right heart failure, the institution of intraaortic balloon counterpulsation caused a significant improvement in cardiac function. Although RV ischemia was not demonstrated, the augmentation of left coronary artery blood flow by intraaortic balloon counterpulsation and subsequent improvement in left ventricular function suggest that left ventricular ischemia contributes to RV dysfunction, presumably through a ventricular interdependence mechanism. Therefore, study of the safety and efficacy of intraaortic balloon counterpulsation in the management of patients with acute right heart dysfunction is warranted.
Collapse
Affiliation(s)
- W C Darrah
- Department of Anaesthesia, London Health Sciences Centre, Ontario, Canada
| | | | | | | |
Collapse
|
12
|
van Hemel NM, Defauw JJ, Guiraudon GM, Kelder JC, Jessurun ER, Ernst JM. Long-term follow-up of corridor operation for lone atrial fibrillation: evidence for progression of disease? J Cardiovasc Electrophysiol 1997; 8:967-73. [PMID: 9300292 DOI: 10.1111/j.1540-8167.1997.tb00618.x] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
INTRODUCTION Currently, surgery- and catheter-mediated ablation is applied when drug refractoriness of atrial fibrillation is evident, although little is known about the long-term incidence of new atrial arrhythmia and the preservation of sinus node function. METHODS AND RESULTS To address this issue, 30 patients with successful corridor surgery for lone paroxysmal atrial fibrillation and normal preoperative sinus node function were followed in a single outpatient department. Five years after surgery, the actuarial proportion of patients with recurrence of atrial fibrillation arising in the corridor was 8% +/- 5%, with new atrial arrhythmias consisting of atrial flutter and atrial tachycardia in the corridor 27% +/- 8%, and with incompetent sinus node requiring pacing therapy 13% +/- 6%. Right atrial transport was preserved in 69% of the patients without recurrence of atrial fibrillation and normal sinus node function. Stroke was documented in two patients. CONCLUSIONS Corridor surgery for atrial fibrillation is a transient or palliative treatment instead of a definitive therapy for drug refractory atrial fibrillation. This observation strongly affects patient selection for this intervention and constitutes a word of caution for other, nonpharmacologic interventions for drug refractory atrial fibrillation.
Collapse
Affiliation(s)
- N M van Hemel
- Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
| | | | | | | | | | | |
Collapse
|
13
|
Abstract
BACKGROUND Mobile right atrial thrombus is an uncommon finding on two-dimensional (2D) echocardiography. Therapeutic alternatives include systemic heparinization, systemic or local thrombolysis, and surgical removal. We report our clinical experience in six patients over a 3-year period (6000 echocardiograms) at a tertiary care referral center. METHODS There were four men and two women with a mean age of 63 years (range: 47 to 73 years). Indications for echocardiography consisted of progressive dyspnea and chest pain in five patients and syncope with chest pain in one patient. RESULTS All were observed to have a mobile thrombus in the right atrium. Ventilation perfusion (V/Q) scanning confirmed V/Q mismatch in all patients. Subsequent echocardiography (minutes to 1 day later) in three patients demonstrated absence of the thrombus suggesting pulmonary embolization. One patient died during transesophageal echocardiography (TEE) and autopsy confirmed a large pulmonary embolization in the main pulmonary artery. Treatment consisted of heparinization in 3 patients, systemic thrombolysis in 1 patient, and surgical removal of the thrombus in 1 patient. At surgery, a long serpiginous thrombus was seen in the right atrium, tethered to a fenestrated eustachian valve. There were 3 deaths: 1 patient treated with heparin; 1 patient treated with thrombolysis; and 1 during TEE. Two of the three patients treated with heparin and one patient undergoing surgical removal survived hospitalization. CONCLUSIONS Mobile thrombus in the right atrium is an unusual echocardiographic finding. It portends a poor prognosis with death due to pulmonary embolism.
Collapse
Affiliation(s)
- C P Shah
- Division of Cardiology and Cardiac Surgery, University Hospital, London, Canada
| | | | | | | | | |
Collapse
|
14
|
Abstract
We report our experience with seven patients who underwent direct surgical ablation of problematic common flutter. Intraoperative mapping was obtained in four patients. Surgical techniques varied over time. A circular incision of the right atrium was performed in the first patient. Two patients had epicardial cryoablation of the isthmus between the inferior vena cava and the tricuspid valve annulus. Four patients had extensive endocardial cryoablation of the isthmus. There were no immediate postoperative complications. One patient had atrial fibrillation 2 months postoperatively and underwent a corridor operation 1 year later. The other six patients are free of arrhythmias without antiarrhythmic drugs. Surgical ablation confirmed that the common form of atrial flutter is associated with a right atrial macroreentrant circuit. One of our intraoperative endocardial maps suggested that variant reentrant circuits can be associated with variant forms of flutter.
Collapse
Affiliation(s)
- G M Guiraudon
- Department of Surgery, London Health Sciences Center, Ontario, Canada
| | | | | | | | | |
Collapse
|
15
|
Guiraudon GM, Klein GJ, Yee R, Guiraudon CM. Surgery for supraventricular tachycardia. Arch Mal Coeur Vaiss 1996; 89 Spec No 1:123-7. [PMID: 8734173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
1995 is the fifth anniversary of the advent of catheter ablation for the treatment of supraventricular tachycardia. Surgery has established the principles of the interventional approaches: 1) identification of the mechanism; 2) localization of the site of the mechanism; 3) identification of the anatomical arrhythmogenic substrate and its localization using preoperative and intraoperative electrophysiological cardiac mapping; 4) ablation of the arrhythmogenic substrate using "surgical" dissection or excision or various forms of energy to neutralize the substrate: cryoablation, laser, etc. Surgical approaches also established the EP interventions as the first line of therapy because they are curative. Currently, surgery for supraventricular tachycardia is essentially confined to atrial fibrillation, and after attempted catheter ablation for the Wolff-Parkinson-White syndrome. Atrial fibrillation is a complex arrhythmia, commonly associated with structural heart disease. To understand atrial fibrillation, a number of premises should be reviewed: atrial functional anatomy, atrial pathology, atrial fibrillation mechanism (s) and clinical presentation. The role of atrial fibrillation in terms of symptoms, morbidity and mortality is not clear because it is difficult to determine if atrial fibrillation is a symptom, a marker, an autonomous disease albeit it is in most cases an aggravating factor. Surgical rationales for atrial fibrillation are based on three concepts: exclusion, fragmentation and channelling. The Corridor operation was the first used direct surgical approach. The Maze operation and other techniques (fragmentation, spiral) have been reported. All surgical techniques have been reported with good results in terms of sinus node function and exercise tolerance, and to various degrees, in terms of atrial contraction. Currently, there is a trend to combine direct atrial fibrillation surgery with surgery for mitral valve albeit beneficial effects are not documented.
Collapse
|
16
|
Thakur RK, Chow LH, Guiraudon GM, Kostuk WJ, Brown JE, Pflugfelder PV, Guiraudon CM. Latissimus dorsi dynamic cardiomyoplasty: role of combined ICD implantation. J Card Surg 1995; 10:295-7. [PMID: 7549185 DOI: 10.1111/j.1540-8191.1995.tb00614.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Latissimus dorsi cardiomyoplasty is a promising surgical therapy in some patients with congestive heart failure. Although the mortality in heart failure patients is attributable primarily to heart failure and ventricular arrhythmias, the mechanism of death after cardiomyoplasty is not well characterized. We describe the clinical course of a patient undergoing cardiomyoplasty and discuss the role of combined use with an implantable cardioverter defibrillator. A 39-year-old man with congestive heart failure due to a massive anterior wall myocardial infarction was evaluated for latissimus dorsi cardiomyoplasty. The patient was in NYHA Functional Class III due to heart failure. He did not have any significant exertional or rest angina. During a Naughton stress test, the patient could exercise for 10 minutes, achieving 4 METS. Pulmonary function study showed a peak V O2 of 22.1 mL/min per kg. Radionuclide angiography demonstrated that the anterior wall was akinetic with a left ventricular ejection fraction of 22%. Cardiac hemodynamic studies suggested moderate pulmonary hypertension, elevated wedge pressure, and suboptimal response to exercise. A Holter recording showed frequent ventricular extrasystoles. Cardiomyoplasty was preferred to heart transplantation because the patient did not have end-stage heart failure. Postoperatively, the patient required low doses of dopamine. He developed recurrent, sustained, and hemodynamically significant episodes of ventricular tachycardia. He was treated with a combination of amiodarone and procainamide. He died 2 days postoperatively with ventricular fibrillation. Ventricular arrhythmias are a major cause of death in patients with heart failure. Latissimus dorsi cardiomyoplasty appears to be a promising but unproven therapy in such patients.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- R K Thakur
- Division of Cardiology, University Hospital, London, Canada
| | | | | | | | | | | | | |
Collapse
|
17
|
Dumas MD, Bach DB, Guiraudon GM. Ruptured spleen as a complication of insertion of an automatic implantable cardioverter-defibrillator. Can Assoc Radiol J 1995; 46:226-8. [PMID: 7538888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
The authors describe a previously unreported complication of insertion of an automatic implantable cardioverter-defibrillator via the left subcostal surgical approach. Splenic hematoma, intraperitoneal hemorrhage and hypotension developed in a 66-year-old man within 5 days of implantation, and the patient underwent splenectomy.
Collapse
Affiliation(s)
- M D Dumas
- Department of Diagnostic Imaging, University Hospital, University of Western Ontario, London
| | | | | |
Collapse
|
18
|
|
19
|
Abstract
Surgical ablation of ventricular tachycardia is generally guided by the results of pre- and intraoperative cardiac mapping. However, in certain situations intraoperative cardiac mapping may not be possible and, therefore, surgery has to be based on information obtained preoperatively. This raises the question whether intraoperative mapping is necessary for the success of this approach. We describe our experience with encircling endocardial cryoablation for ischemic VT and examine the contribution of intraoperative mapping for this procedure. Thirty-three patients with inducible VT refractory to medical therapy and a well defined anatomic scar were considered for surgery. All patients underwent baseline electrophysiology study and intraoperative mapping was attempted during normothermic cardiopulmonary bypass. In 14 patients, VT was inducible intraoperatively (Group 1) and surgical ablation was guided by this information, whereas in 19 patients, VT could not be mapped for various reasons (Group 2). Reasons for failure to obtain intraoperative map included noninducibility (3), nonsustained VT (8), polymorphic VT (4), VF (3), and incessant VT with hemodynamic collapse and cardiac arrest (1). The two groups did not differ with respect to age, location of myocardial infarction, or preoperative left ventricular ejection fraction. The operative procedures were similar in the two groups with respect to aortic cross clamp time, cardiopulmonary bypass time, number of cryoablation lesions, concomitant revascularization, aneurysmectomy, and ICD implantation. Encircling endocardial cryoablation was performed in 32 patients and one patient underwent partial right ventricular free wall disconnection (RV infarct). Thirteen patients underwent concomitant coronary artery bypass grafting (5 in Group 1 and 8 in group 2). One patient had prophylactic ICD patches (Group 1).(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- R K Thakur
- Department of Medicine, University of Western Ontario, London, Canada
| | | | | | | | | |
Collapse
|
20
|
Guiraudon GM, Thakur RK, Klein GJ, Yee R, Guiraudon CM, Sharma A. Encircling endocardial cryoablation for ventricular tachycardia after myocardial infarction: experience with 33 patients. Am Heart J 1994; 128:982-9. [PMID: 7942492 DOI: 10.1016/0002-8703(94)90598-3] [Citation(s) in RCA: 50] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Encircling endocardial cryoablation, consisting of circumferential cryoablation of the infarct scar, can be curative in selected patients with ventricular tachycardia (VT). We describe our experience with and long-term outcome in 33 patients undergoing this procedure. The interval between myocardial infarction and the onset of tachycardia varied from 2 weeks to 22 years (mean 38 +/- 63 months and median 3 months). All patients had a left ventricular aneurysm (anterior in 20, posterior in 12, and lateral in 1) and significant coronary artery disease. Fourteen patients had clinical evidence of heart failure preoperatively. Twenty-eight patients had sustained monomorphic VT (incessant in 3); 3 had polymorphic or nonsustained tachycardia; 2 had primary ventricular fibrillation; and 1 had associated Wolff-Parkinson-White syndrome. Surgery was undertaken after failed drug therapy and consideration of left ventricular anatomy and function. At surgery, 32 patients had encircling endocardial cryoablation, and 1 patient had partial right ventricular free-wall disconnection (right ventricular infarct). Thirteen patients underwent concomitant coronary artery bypass grafting. An implantable cardioverter defibrillator (ICD) was implanted in 2 patients and prophylactic ICD patches in 1. One patient died postoperatively; 3 had recurrent VT perioperatively; 1 was treated with amiodarone; and 2 had ICD implantation. During long-term follow-up (mean 5 years), all patients who were free of tachycardia at discharge remained alive and free of arrhythmias or syncope. The patient receiving amiodarone sustained a cardiac arrest subsequently and received an ICD implant. One patient with an ICD continued to receive appropriate shocks frequently and died 2 years after surgery. Nine patients had congestive heart failure postoperatively.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- G M Guiraudon
- Department of Surgery, University of Western Ontario, University Hospital, London, Canada
| | | | | | | | | | | |
Collapse
|
21
|
Thakur RK, Klein GJ, Yee R, Guiraudon GM. Complications of radiofrequency catheter ablation: a review. Can J Cardiol 1994; 10:835-9. [PMID: 7954019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
Radiofrequency catheter ablation has revolutionized the management of patients with supraventricular tachycardias. Although initial reports were very favourable, it is becoming apparent that radiofrequency catheter ablation may lead to some potentially serious complications. Complication rate for accessory pathway ablation ranges from 1.8 to 4% and the risk of atrioventricular (AV) block for 'AV nodal modification' ranges from 1.3 to 8%. It is likely that complications are underreported and the true incidence may be higher. Some of these complications are probably related to operator experience or the volume of ablations performed at the centre, but other complications, such as systemic embolism, may be sporadic and unrelated to experience or volume. Although radiofrequency catheter ablation has emerged as an excellent therapeutic tool, the potential complications and limitations should be recognized.
Collapse
Affiliation(s)
- R K Thakur
- Arrhythmia Service, University Hospital, London, Ontario
| | | | | | | |
Collapse
|
22
|
Abstract
The surgical treatment of the Wolff-Parkinson-White syndrome made its appearance in 1968 when Dr W. C. Sealy performed the first direct surgical intervention for ablating an accessory connection in a patient with incessant atrioventricular reentrant tachycardia. The surgical approach fell into disfavor in 1990 when catheter ablation using radiofrequency energy was adopted into widespread use. In this presentation, I will attempt to assess the scientific value of the surgical experience using the scholarly tool, the "retrospectroscope," and also to answer the questions, Was it worth it? What was learned? and What was achieved? We conclude that a large body of scientific knowledge and skill was brought to light by this experience and, of even more importance, passed on for best use to the catheter surgeons.
Collapse
Affiliation(s)
- G M Guiraudon
- Department of Surgery, University Hospital, London, Ontario, Canada
| |
Collapse
|
23
|
Abstract
Catheter ablation has greatly altered surgical referral patterns for the Wolff-Parkinson-White syndrome. We describe 51 patients (aged 9 to 63 years; 35 male, 16 female) referred for operation from our institution and elsewhere between August 1990 and August 1993, coincident with the inception of our ablation program. During the same period, 375 patients with problematic Wolff-Parkinson-White syndrome had ablation procedures. Operation was the initial therapy in 26 patients, due to physician preference in 23 and the need for a concomitant cardiac operation in 3. Operation was related to ablation failure in 22 patients and was urgent in 3 patients. Previous ablation was not associated with added surgical difficulties, and all pathways were ablated intraoperatively on the first attempt using the epicardial approach. Visible epicardial lesions were observed in 8 patients at the site of the accessory pathway. In 2 patients, the lesions were remote to the atrioventricular ring. There was a striking significant increase in proportion of right free wall pathways after attempted ablation (27% versus 8%) as compared with the preablation era. We conclude that previous attempted ablation does not impair efficacy and safety of operative therapy. Operation remains a useful alternative for ablation failure and as a back-up for acute complications.
Collapse
Affiliation(s)
- G M Guiraudon
- Department of Surgery, University of Western Ontario, University Hospital, London, Canada
| | | | | | | | | |
Collapse
|
24
|
van Hemel NM, Defauw JJ, Kingma JH, Jaarsma W, Vermeulen FE, de Bakker JM, Guiraudon GM. Long-term results of the corridor operation for atrial fibrillation. Br Heart J 1994; 71:170-6. [PMID: 8130027 PMCID: PMC483639 DOI: 10.1136/hrt.71.2.170] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
OBJECTIVE To investigate the long-term results of the corridor operation in the treatment of symptomatic atrial fibrillation refractory to drug treatment. BACKGROUND The corridor operation is designed to isolate from the left and right atrium a conduit of atrial tissue connecting the sinus node area with the atrioventricular node region in order to preserve physiological ventricular drive. The excluded atria can fibrillate without affecting the ventricular rhythm. This surgical method offers an alternative treatment when atrial fibrillation becomes refractory to drug treatment. PATIENTS From 1987 to 1993, 36 patients with drug refractory symptomatic paroxysmal atrial fibrillation underwent surgery. The in hospital rhythm was followed thereafter by continuous rhythm monitoring and with epicardial electrograms. After discharge Holter recording and stress testing were regularly carried out to evaluate the sinus node function and to detect arrhythmias; whereas Doppler echocardiography was used to measure atrial contraction and size. MAIN OUTCOME MEASURES Maintained absence of atrial fibrillation without drug treatment after operation; preservation of normal chronotropic response in the sinus node. RESULTS The corridor procedure was successful in 31 (86%) of the 36 patients. After a mean (SD) follow up of 41 (16) months 25 (69%) of the 36 patients were free of arrhythmias without taking drugs (mean (SE) actuarial freedom at four years 72 (9)%)). Paroxysmal atrial fibrillation recurred in three patients; paroxysmal atrial flutter (two patients) and atrial tachycardia (one patient) developed in the corridor in three others. Among the 31 patients in whom the operation was successful sinus node function at rest and during exercise remained undisturbed in 26 and 25 patients respectively (mean (SE) actuarial freedom of sinus node dysfunction at four years (81(7)%)). Pacemakers were needed in five (16%) of the 31 patients for insufficient sinus node rhythm at rest only. Doppler echocardiography showed maintenance of right atrial contribution to right ventricle filling in 26 of the 31 patients after operation in contrast to the left atrium, which never showed such contribution. His bundle ablation was performed and a pacemaker implanted in the five patients in whom the corridor operation was unsuccessful. CONCLUSION These results substantiate the idea of this surgical procedure. Modification of the technique is, however, needed to achieve a reliable isolation between left atrium and corridor, which would make this experimental surgery widely applicable in the treatment of drug refractory atrial fibrillation.
Collapse
Affiliation(s)
- N M van Hemel
- Department of Cardiology, St Antonius Hospital, Nieuwegein, Netherlands
| | | | | | | | | | | | | |
Collapse
|
25
|
Murkin JM, Lux J, Shannon NA, Guiraudon GM, Menkis AH, McKenzie FN, Novick RJ. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J Thorac Cardiovasc Surg 1994; 107:554-61. [PMID: 7508071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
BACKGROUND Patients with heart disease are frequently maintained on a regimen of aspirin because of its ability to decrease thrombotic complications and reduce the prevalence of unstable angina and myocardial infarction. Aspirin-induced platelet acetylation also increases bleeding caused by impairment of platelet function during cardiac surgery. METHODS Between October 1990 and November 1991 this double-blind, randomized, placebo-controlled, parallel group interventional study examined the efficacy of high-dose aprotinin administration (up to 7 million KIU) to decrease blood loss and transfusion requirements in patients receiving aspirin within 48 hours of undergoing coronary bypass or valvular heart operations. Primary outcome measures in this study were total volume of blood loss (intraoperative blood loss plus postoperative chest tube drainage) and volume of transfusion during hospitalization. RESULTS Patients treated with aprotinin (n = 29) had significantly lower total blood loss (1409 +/- 232 ml versus 2765 +/- 248 ml; p = 0.0002), intraoperative blood loss (503 +/- 53 ml versus 1055 +/- 199 ml; p = 0.0001), postoperative blood loss (906 +/- 204 ml versus 1710 +/- 202 ml; p = 0.0074), and prevalence of transfusion (59% versus 88% of patients; p = 0.016) than the placebo group (n = 25). The prevalence of complications including myocardial infarction was similar in the two groups. CONCLUSIONS High-dose aprotinin significantly reduces blood loss and red blood cell transfusions in patients receiving aspirin who undergo cardiac operations.
Collapse
Affiliation(s)
- J M Murkin
- Department of Anaesthesia, University Hospital, University of Western Ontario, London, Canada
| | | | | | | | | | | | | |
Collapse
|
26
|
Novick RJ, Menkis AH, Guiraudon GM, Sandler D, Pflugfelder PW, Kostuk WJ, Yee R, Klein GJ, Powell AM, McKenzie FN. Heart transplantation after cardioverter-defibrillator implantation. A case control study. Chest 1993; 103:1710-4. [PMID: 8404088 DOI: 10.1378/chest.103.6.1710] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
A case control study was performed to determine whether previous implantable cardioverter-defibrillator (ICD) insertion adversely affects outcome after heart transplantation. Six male heart transplant recipients who had undergone ICD insertion 12 +/- 5 months before heart transplantation were compared to a cohort of six heart transplant recipients who were matched according to age, preoperative status and hemodynamics, date of transplantation, graft ischemic time, history of a previous cardiac operation, and duration of follow-up. There were no significant differences in operating room time, chest tube drainage, time to extubation, and the duration of intensive care unit or hospital stay between the two groups. Furthermore, there were no significant differences in the number of units of packed cells, fresh frozen plasma, platelets and cryoprecipitate transfused. The number of treated rejection episodes and the number of patients requiring intravenous antibiotics for infection in the first 90 days was identical between groups. It was concluded that heart transplantation after ICD implantation did not appear to carry more risk than heart transplantation after a previous cardiac operation. Our limited experience supports the potential use of the ICD in patients with life-threatening ventricular dysrhythmias who are awaiting transplantation.
Collapse
Affiliation(s)
- R J Novick
- Division of Cardiovascular-Thoracic Surgery, University Hospital, London, Ontario, Canada
| | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Natale A, Wathen M, Wolfe K, Yee R, Guiraudon GM, Klein GJ. Comparative atrioventricular node properties after radiofrequency ablation and operative therapy of atrioventricular node reentry. Pacing Clin Electrophysiol 1993; 16:971-7. [PMID: 7685896 DOI: 10.1111/j.1540-8159.1993.tb04570.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
The anatomical substrate for atrioventricular (AV) node reentry is unclear. To gain insights into the mechanism of cure of AV node reentry by nonpharmacological techniques, we compared AV node properties in 53 patients undergoing operative therapy (perinodal dissection) and 43 undergoing radiofrequency ablation (28 posterior approach, 15 anterior approach). Anterior radiofrequency ablation was associated with significant AH prolongation (62 +/- 18 msec vs 136 +/- 64 msec, P < 0.0001), loss of "fast" pathway physiology, and no change in the anterograde refractory period of the AV node (273 +/- 24 msec vs 268 +/- 28 msec, P = NS). Posterior radiofrequency ablation did not change the AH interval (67 +/- 17 msec vs 68 +/- 17 msec, P = NS), prolonged AV node effective refractory period (275 +/- 48 msec vs 320 +/- 55 msec, P < 0.0001), and was associated with loss of "slow pathway" physiology. Operative treatment prolonged the AH interval (66 +/- 18 msec vs 83 +/- 37 msec, P < 0.0001) and the AV node effective refractory period (264 +/- 52 msec vs 364 +/- 112 msec, P < 0.0001), and affected dual pathway physiology inconsistently. These data support the view that the "fast" and "slow" pathways are distinct perinodal entities that can be selectively ablated. The operative approach causes more diffuse and variable injury to the AV node region.
Collapse
Affiliation(s)
- A Natale
- Department of Medicine, University of Western Ontario, London, Canada
| | | | | | | | | | | |
Collapse
|
28
|
Abstract
Because of its high efficacy and low morbidity radiofrequency energy catheter ablation techniques have toppled the hierarchy of choice in the electrophysiological intervention armamentum. This review assesses current role of surgery and its foreseeable future. Most accessory AV pathways can be attained by endocardial manipulation and ablated. Surgical dissection of accessory pathways on the beating heart had documented that most pathways were paraannular, although right-sided pathways may be distant to the annulus. Results of accessory pathway ablation have shown that right-sided pathways are difficult to approach and ablate. Surgical ablation may currently be considered after failed catheter ablation. AV nodal modification using catheter ablation also yields excellent results. Radiofrequency energy creates a discrete lesion associated with discrete electrophysiological alteration. Surgical dissection is associated with more diffuse and extensive anatomical and electrophysiological changes and is no longer used even after failed catheter ablation. The arrhythmogenic anatomical substrate associated with atrial flutter is not yet well delineated in the coronary sinus os region. How to extend tissue modification for uniform success here is not yet known. Further surgical approach combined with extensive intraoperative cardiac mapping may ultimately prove a valuable guide for subsequent catheter technique. Atrial fibrillation is the last surgical frontier unchallenged by catheter techniques. Arrhythmogenic anatomical substrate is diffuse spreading over the entire atrial myocardium without a discrete target. The associated pathology is diffuse, severe, and progressive and present even in the so-called lone atrial fibrillation. Progression of underlying pathology can nullify the best designed surgical rationale in terms of sinus node chronotropic function, and atrial contractility. Currently used surgical techniques, i.e., the corridor and the Maze operations, have contributed to a better selection of patients. Surgery is still associated with significant morbidity and relative efficacy, and may be improved before becoming the electrophysiological intervention of choice for atrial fibrillation. In conclusion, atrial fibrillation is a greater surgical challenge, but has to be met with the same standard used for other supraventricular tachycardias.
Collapse
Affiliation(s)
- G M Guiraudon
- Faculty of Medicine, Department of Surgery, University of Western Ontario, University Hospital, London, Canada
| | | | | |
Collapse
|
29
|
Guiraudon GM. Surgical treatment of atrial fibrillation. Herz 1993; 18:51-9. [PMID: 8454252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Recently, two new rationale for surgical treatment of atrial fibrillation have been developed which have been used, initially, primarily in patients with lone atrial fibrillation. We performed the "corridor" operation in eleven patients with paroxysmal or chronic atrial fibrillation. Postoperatively, eight patients had normal sinus rhythm, one had a junctional rhythm, one patient had atrial tachycardia and one had intermittent atrial flutter/fibrillation with sinus bradycardia. During a mean observation period of 18 months, recurrent intermittent atrial fibrillation occurred in two patients. Another study reported the results of 20 patients with paroxysmal atrial fibrillation. During a mean observation period of 32 +/- 14 months, one patient had a brief episode of atrial fibrillation and three patients had atrial tachycardia amenable to antiarrhythmic drug treatment. The "Maze" operation was performed in 22 patients with resistant lone atrial fibrillation or atrial flutter. Postoperatively, eight patients had atrial flutter/fibrillation which, however, could be controlled in three with antiarrhythmic drug treatment. In all patients serious symptoms were improved but adjunctive measures and/or antiarrhythmic drugs were required frequently. There was no intraoperative mortality with either the corridor or the Maze operation but substantial postoperative morbidity was observed which, currently, exceeds that of the natural history or other ablative techniques.
Collapse
Affiliation(s)
- G M Guiraudon
- Department of Surgery, Faculty of Medicine, University of Western Ontario, University Hospital, London, Canada
| |
Collapse
|
30
|
Abstract
It has been demonstrated recently that both biphasic and sequential pulse defibrillation shocks are superior to monophasic defibrillation shocks in animals and humans. There is little information directly comparing these two waveforms when pulse characteristics, subjects, and total electrode surface areas are kept constant. We determined the defibrillation threshold intraoperatively in 12 patients undergoing arrhythmia surgery, with the use of two or three patch electrodes (Medtronic 6891 and 6892), while keeping the electrode surface area constant. Patients were randomized in a crossover design for determinations of defibrillation threshold by means of biphasic and sequential pulse shocks. Leading-edge delivered current and delivered energy were significantly lower with sequential pulse shocks than with biphasic shocks (delivered energy means +/- SEM 3.6 +/- 0.7 joules vs 5.5 +/- 0.9 joules, respectively). We conclude that sequential pulse defibrillation with three defibrillating electrodes provides an important current delivery system not matched by biphasic shocks with two electrodes when subjects, waveform characteristics, and total electrode surface areas are kept constant.
Collapse
Affiliation(s)
- D L Jones
- Department of Medicine, University of Western Ontario, London, Canada
| | | | | | | |
Collapse
|
31
|
Abstract
This review analyzes the role of coronary artery bypass grafting in ventricular arrhythmia associated with exertion, problematic sustained ventricular tachycardia, and sudden cardiac death associated with documented ventricular arrhythmia, or first manifestation of coronary artery disease. Specifically discussed is the role of acute ischemia in initiating and perpetuating ventricular arrhythmia. Coronary artery bypass grafting is indicated as a curative intervention for ventricular arrhythmia, but in only one rare instance: exercise-induced ischemia associated with problematic sustained ventricular arrhythmia, when the tachycardia is documented as being induced by acute ischemia. In other instances, indications for coronary artery bypass grafting follow the current guidelines based on clinical trials. Patients with the most severely damaged coronary artery anatomy associated with impaired left ventricular dysfunction have their life expectancy significantly prolonged after coronary artery bypass grafting. These results have been presented as evidence that coronary artery bypass grafting prevents ventricular arrhythmia and sudden cardiac death by modifying the two most powerful predicting factors of sudden cardiac death: coronary artery anatomy and left ventricular function.
Collapse
|
32
|
Defauw JJ, Guiraudon GM, van Hemel NM, Vermeulen FE, Kingma JH, de Bakker JM. Surgical therapy of paroxysmal atrial fibrillation with the "corridor" operation. Ann Thorac Surg 1992; 53:564-70; discussion 571. [PMID: 1554262 DOI: 10.1016/0003-4975(92)90312-r] [Citation(s) in RCA: 82] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Patients with paroxysmal atrial fibrillation may be extremely disabled despite medical therapy. Based on recent concepts of atrial fibrillation, a surgical open heart procedure was designed to isolate a "corridor" from the right and the left atrium. The corridor consists of the sinus node area, the atrioventricular nodal junction, and the connecting right atrial mass, small enough to prevent atrial fibrillation. Between 1987 and 1990, 20 patients with severely disabling symptoms due to frequent paroxysmal atrial fibrillation underwent the corridor operation, with permanent success in 16 patients. In 8 patients, left atrium to corridor conduction reappeared shortly after the procedure. Reoperation was performed in these patients without extracorporeal circulation. The site of persistent conduction between the left atrium and the corridor could consistently be localized adjacent to the coronary sinus. Nevertheless, reoperation failed to isolate permanently the corridor in 4 patients. During a mean follow-up of 20 months, atrial fibrillation dominating the ventricles was never observed nor inducible in the corridor in the 16 patients with a successful operation. In all cured patients, sinus node function remained undisturbed. Paroxysmal atrial flutter inside the corridor arose in 1 patient and a paroxysmal focal tachycardia in another. All 16 cured patients experienced a clear improvement in quality of life. Refinement of the surgical technique to obtain persistent isolation between the left atrium and the corridor is needed. These results demonstrate that the concept of the corridor operation is sound and justify its use in the treatment of drug-refractory paroxysmal atrial fibrillation.
Collapse
Affiliation(s)
- J J Defauw
- Department of Cardiothoracic Surgery, St Antonius Hospital, Nieuwegein, The Netherlands
| | | | | | | | | | | |
Collapse
|
33
|
Yee R, Klein GJ, Leitch JW, Guiraudon GM, Guiraudon CM, Jones DL, Norris C. A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator. Nonthoracotomy approach to implantation. Circulation 1992; 85:196-204. [PMID: 1728450 DOI: 10.1161/01.cir.85.1.196] [Citation(s) in RCA: 91] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
A transvenous lead system for implantable defibrillators would obviate a surgical thoracotomy and reduce the morbidity and mortality associated with implantation. We evaluated the clinical performance of a new nonthoracotomy lead system that included a defibrillation lead in the coronary sinus. At the time of defibrillator implantation, transvenous defibrillation leads were inserted percutaneously through the left subclavian vein into the right ventricular apex (RVA), superior vena cava (SVC), and distal coronary sinus (CS) under fluoroscopic guidance. A subcutaneous patch electrode (SQ) was also available if required. The first single- or dual-pathway electrode configuration that successfully terminated three of four ventricular fibrillation episodes using 18 J or less was implanted. Eleven men and three women aged 39-77 years (60.0 +/- 10.1 years) with left ventricular ejection fraction ranging from 16% to 63% (33.4 +/- 13.1%) were evaluated. Nine presented with ventricular tachycardia, three had ventricular fibrillation, and two had both. A totally transvenous lead system (RVA/CS/SVC) was implanted in seven patients (50%) with a mean defibrillation threshold of 15.6 +/- 2.9 J (10-18 J). Four patients received a partial transvenous lead system (RVA/CS/SQ). An effective nonthoracotomy lead system was not found in three patients; they received epicardial electrodes. After cumulative follow-up of 73 patient-months, nine patients remain alive and free of problems related to the implanted nonthoracotomy leads. One patient died of respiratory failure 3 months after defibrillator implant, and the leads from another patient were removed at 9 months because of bacterial infection. A transvenous lead system that includes a defibrillation lead in the coronary sinus is a safe, reliable, and, at least in the short term, effective nonthoracotomy approach for automatic defibrillator implantation.
Collapse
Affiliation(s)
- R Yee
- Department of Medicine, University Hospital, London, Ontario, Canada
| | | | | | | | | | | | | |
Collapse
|
34
|
Guiraudon GM, Klein J, Yee R. Surgery for supraventricular tachyarrhythmias. Schweiz Med Wochenschr 1991; 121:1965-9. [PMID: 1763306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Since the first successful surgical intervention for Wolff-Parkinson-White syndrome by W. C. Sealy, a surgical electrophysiological intervention has been developed for every single supraventricular arrhythmia. The surgical rationale is based on the site of the mechanism of the arrhythmia and associated pathology which characterizes the "arrhythmogenic substrate". Wolff-Parkinson-White syndrome is a congenital heart disease characterized by an accessory atrioventricular connection distinct from the AV node-His bundle system. It is associated with AV reentrant tachycardia and/or atrial fibrillation with fast ventricular responses via the accessory pathway. The current surgical management is ablation of the accessory pathway using either an endocardial dissection or epicardial approach. Surgical ablation is associated with high efficacy and low morbidity. Epicardial dissection of the accessory pathway on the beating heart has helped to localize variant accessory pathways associated with Coumel's tachycardia or Mahaim's fiber electrophysiological entity. AV nodal reentrant tachycardia can be cured using direct AV nodal dissection (or perinodal cryoablation). Atrial flutter can be interrupted by cryoablation of the arrhythmogenic substrate located in the coronary sinus orifice of the region modifying atrial inputs. Chronotropic atrial function abolished by chronic or paroxysmal idiopathic atrial fibrillation can be restored using the corridor operation (sinus node-AV node insulation). Surgery is an alternative in patients with resistant atrial tachycardias. Currently surgery is indicated only after other non-invasive EP interventions have been either attempted or rejected.
Collapse
|
35
|
Abstract
Success rates of approximately 90% have recently been reported with radiofrequency catheter ablation of accessory pathways. This study determined whether this success could be repeated using a conservative approach generally limiting fluoroscopy time to 1 hour. Consecutive patients referred for management of arrhythmias associated with accessory atrioventricular pathways were included over a 9-month period. Ablation was attempted in 75 patients with 84 pathways. Overall success rate (including second attempts in 9 patients) was 60 of 84 accessory pathways (71%). Success rates for the first 3 months (n = 23) were 52%, the second 3 months (n = 23) 60% and the last 3 months (n = 38) 90%. Success rate varied with pathway location, with left lateral pathways having the best early success rates. Mean fluoroscopy time for successful procedures of 33 +/- 21 minutes was shorter than the time for unsuccessful procedures of 63 +/- 24 minutes (p = 0.001). There were no major complications and no patients with successful procedures (n = 53) have had recurrence of accessory pathway conduction or reciprocating tachycardia (follow-up 1 to 10 months). A conservative approach can yield success rates approaching 90% in a short time. The absence of major complications supports earlier reports suggesting that radiofrequency catheter ablation of accessory pathways is a reasonable first-line therapy in the Wolff-Parkinson-White syndrome.
Collapse
Affiliation(s)
- R A Leather
- Department of Medicine, University of Western Ontario, London, Canada
| | | | | | | | | | | |
Collapse
|
36
|
Abstract
Optimal mitral valve operation requires adequate exposure without impairment of atrial physiology, namely sinus node and atrioventricular node function. We used an extended vertical transseptal atrial approach in 34 consecutive patients. The extended vertical transseptal approach combines two semicircular atrial incisions circumscribing the tricuspid and mitral annuli anteriorly and superiorly, allowing exposure of the mitral valve by deflecting the ventricular side using stay sutures. The right atrium is opened anteriorly along the atrioventricular sulcus. The atrial septum is incised vertically through the fossa ovalis. The right atriotomy is extended superiorly in the right coronary fossa between the right atrial appendage and the atrioventricular sulcus to meet the septal incision. The two joint incisions are extended onto the left atrial roof transversely. At this point, the two semicircular incisions are performed and joined, and mitral valve operation is performed. There were 18 women and 16 men. Five patients had ischemic mitral valve regurgitation, 18 had mitral valve prolapse, and 11 had rheumatic heart disease. The mitral valve was replaced in 17 patients and repaired in 17. There were no perioperative complications associated with the atriotomies, ie, no bleeding, no atrioventricular nodal dysfunction, and no sinus node dysfunction. The extended vertical transatrial septal approach provides good mitral valve exposure without inherent complications.
Collapse
Affiliation(s)
- G M Guiraudon
- Department of Surgery, University Hospital, University of Western Ontario, London, Canada
| | | | | |
Collapse
|
37
|
Abstract
Patients with automatic defibrillators frequently require chronic antiarrhythmic drug therapy or receive acute therapy with the onset of symptoms. The effects on energy requirements for defibrillation of lidocaine hydrochloride and verapamil hydrochloride, two commonly used antiarrhythmic agents, were examined in 20 successive patients undergoing corrective arrhythmia surgery. The minimum energy requirement for ventricular defibrillation before and 5 minutes after the administration of 150 mg of lidocaine intravenously (n = 8), or 10 minutes after 10 mg of verapamil intravenously (n = 12), were determined. Each patient was assigned to receive either verapamil or lidocaine. Three mesh coil defibrillating electrodes (Medtronic 6891, 6892) were sutured to the epicardium of the right and left ventricles. Ventricular fibrillation was induced using alternating current. After a minimum of 10 seconds of fibrillation, the minimum energy for defibrillation was established using sequential pulse defibrillation. The preselected drug was then infused and the ventricular defibrillation energy was again determined after 5 or 10 minutes circulation time. Lidocaine did not alter the minimum energy for defibrillation (3.0 +/- 1.4 J vs. 3.0 +/- 1.8 J, mean +/- SD), despite plasma levels of lidocaine that averaged 13.2 +/- 1.9 mumol/l. In contrast, verapamil significantly increased (3.9 +/- 2.2 J vs. 6.5 +/- 2.9 J) the minimum energy necessary for defibrillation. The difference in defibrillation energy was significantly correlated to the fall in systolic blood pressure induced by verapamil administration (r = 0.72). These data reinforce the necessity for determining efficacy of defibrillation when medication changes are instituted. Verapamil should be used with caution in patients with automatic defibrillators and marginal defibrillation threshold.
Collapse
Affiliation(s)
- D L Jones
- Department of Medicine, University of Western Ontario, University Hospital, London, Canada
| | | | | | | | | | | |
Collapse
|
38
|
Teo WS, Yee R, Klein GJ, Guiraudon GM, Leitch JW. Hypothesis testing as an approach to the analysis of complex tachycardias--an illustrative case of a preexcitation variant. Pacing Clin Electrophysiol 1991; 14:1503-13. [PMID: 1721133 DOI: 10.1111/j.1540-8159.1991.tb04072.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
The correct elucidation of the electrophysiological substrate and mechanism(s) responsible for a complex arrhythmia requires a systematic approach to the analysis of the electrophysiological data. One approach calls for the formulation of a set of hypotheses that could explain the data obtained during the study. The hypotheses are then tested for compatibility with phenomena observed and the one that agrees with the majority of the findings would represent the most tenable explanation. We present the case of a young girl with a wide QRS complex tachycardia and a history of ventricular preexcitation that illustrates this approach. The complexities were resolved only after intraoperative analysis and surgical ablation of a right-sided accessory pathway with decremental properties, and provides further insight into our understanding of the nodoventricular Mahaim fiber.
Collapse
Affiliation(s)
- W S Teo
- Department of Medicine, University Hospital, London, Ontario, Canada
| | | | | | | | | |
Collapse
|
39
|
Abstract
Operative ablation of accessory pathways depends critically on preoperative localization when technical limitations preclude complete intraoperative mapping. To assess the accuracy of localization, 345 patients undergoing operative ablation were studied; 316 (91.6%) had a single accessory pathway and 29 (8.4%) had multiple accessory pathways. The electrophysiologic study was diagnostically complete and accurate in 294 patients (93%) with a single accessory pathway and 19 (61%) with multiple accessory pathways. A left lateral accessory pathway was most accurately localized with excellent sensitivity (99%) and positive predictive value (98.5%). Diagnostic errors occurred in 33 patients because of 1) incorrect localization (n = 16), 2) failure to detect a second pathway (n = 9), and 3) diagnosis of a second pathway not verified intraoperatively (n = 8). Multiple pathways were more prevalent in the group with errors (33.3% vs. 5.8%, p = 0.0001), as were unidirectional pathways (48.5% vs. 24.3%, p = 0.003). It is concluded that preoperative localization of accessory pathways is sufficiently accurate to allow intraoperative mapping to be brief and focused.
Collapse
Affiliation(s)
- W S Teo
- Department of Medicine, University Hospital, London, Ontario, Canada
| | | | | | | | | |
Collapse
|
40
|
Abstract
Some patients with electrophysiologic features suggesting nodoventricular fibers have been shown to have right parietal atrioventricular (AV) accessory pathways with decremental conduction properties intraoperatively. The experience with 11 patients (7 women and 4 men, mean age +/- standard deviation 25 +/- 5 years) who had electrophysiologic features consistent with a nodoventricular pathway and who underwent operative correction was reviewed. At electrophysiologic study, all patients had absent or minimal preexcitation in sinus rhythm. During atrial pacing and extrastimulus testing, maximal preexcitation with left bundle branch block morphology developed and the AH and AV intervals progressively prolonged. Preexcited tachycardia was initiated in all patients (AV reentrant tachycardia in 10 patients and AV node reentrant tachycardia in 1 patient). At operation all patients had a right parietal accessory pathway demonstrated. Intraoperative mapping demonstrated the earliest site of ventricular activation during anterograde preexcitation to be at the midanterior right ventricle, consistent with insertion of these pathways into the right bundle branch system, in 7 patients. The ventricular insertion was at the AV groove in 4 patients, in keeping with the typical Wolff-Parkinson-White syndrome. Retrograde conduction over the pathway was not demonstrated in any patient. Two patients had evidence of a second accessory AV pathway in the left paraseptal region. Operative AV node ablation was electively performed in 2 patients without affecting preexcitation in either case. In 1 of these patients, accessory pathway conduction was temporarily abolished by ice mapping in the right anterolateral AV groove.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- C J Murdock
- Arrhythmia Service, University Hospital, London, Ontario, Canada
| | | | | | | | | | | |
Collapse
|
41
|
Teo WS, Klein GJ, Guiraudon GM, Yee R, Leitch JW, McLellan D, Leather RA, Kim YH. Multiple accessory pathways in the Wolff-Parkinson-White syndrome as a risk factor for ventricular fibrillation. Am J Cardiol 1991; 67:889-91. [PMID: 2011990 DOI: 10.1016/0002-9149(91)90626-v] [Citation(s) in RCA: 31] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- W S Teo
- Department of Medicine, University Hospital, London, Ontario, Canada
| | | | | | | | | | | | | | | |
Collapse
|
42
|
Abstract
His bundle cryosurgical ablation using a closed heart anterior septal approach was used in 6 patients. There were 3 men and 3 women, aged 24 to 73 years. Three patients had atrial fibrillation and 2 patients had atrial flutter (2 with combined episodes of atrial tachycardia). One patient had atrial tachycardia. Five patients had no structural heart disease and 1 patient had left ventricular dilatation (ejection fraction, 0.35). All patients undergoing His bundle cryosurgical ablation had permanent heart block without intraoperative complications (mean follow-up, 25 months). Closed heart anteroseptal cryoablation of the His bundle is effective and is an alternative to attempted catheter ablation.
Collapse
Affiliation(s)
- Y A Louagie
- Department of Surgery, University of Western Ontario, University Hospital, London, Canada
| | | | | | | |
Collapse
|
43
|
Abstract
A 6 month old infant with known Wolff-Parkinson-White syndrome presented with an out of hospital cardiac arrest. An electrocardiogram in the emergency department demonstrated atrial fibrillation with rapid ventricular response. The child subsequently was resuscitated and underwent successful interruption of an accessory connection after failing medical therapy. This case underlines the need to reassess the indications for invasive electrophysiologic testing in young children.
Collapse
Affiliation(s)
- H C Rosenberg
- Department of Pediatrics, Children's Hospital of Western Ontario, London, Canada
| | | | | | | | | | | |
Collapse
|
44
|
Abstract
Atrial flutter is associated with a macro-reentrant loop including an area of slow conduction cryoablation of which prevents atrial flutter to occur. Three patients underwent such intervention. Atrial fibrillation is associated with multiple reentrant circuits (leading circle of Allessie) that requires a critical surface area to perpetuate. We have designed an operation, the corridor operation, which isolate the sinus node and the AV node within a small segment of atrial tissue, to restore the chronotropic function of the sinus node. Nine patients underwent the corridor operation at our institution. There were eight men and one woman. Five had incessant atrial fibrillation and four paroxysmal. One patient had associated mitral valve stenosis and one cardiomyopathy. There were no perioperative complications. Six patients had normal sinus node function postoperatively including all the four patients with documented normal sinus node function preoperatively. Three patients required implantation of an AAI pacemaker. Two patients had recurrence of atrial fibrillation within the corridor. Our experience suggests that the corridor operation should be restricted to patients with documented good sinus node function and without structural heart disease. Our experience with five patients with paroxysmal sinus node tachycardia has been disappointing. Only one patient had long-term success although better series have been published.
Collapse
Affiliation(s)
- G M Guiraudon
- Department of Surgery, University of Western Ontario University Hospital, London, Canada
| | | | | | | | | | | |
Collapse
|
45
|
Abstract
We report our experience with 43 consecutive patients with left free wall pathways operated on since December 1988 using a modified direct epicardial approach through a medial sternotomy, without the adjunct of normothermic cardiopulmonary bypass. The left atrioventricular sulcus is exposed by dislocating the heart cephalad and to the right using a sling made of a large sponge passed around the ventricle through the transverse sinus. While the arterial pressure is monitored, the heart is positioned to obtain adequate exposure without compromising the ventricular function. The left atrioventricular junction is exposed using a direct approach. The epicardium is incised along the ventricular edge and a plane of dissection is identified and opened using blunt dissection over the ventricular wall. The entire left atrioventricular junction can be exposed. After dissection, electrophysiological testing is repeated to assess accessory pathway conduction. Epicardial cryoablation was used when accessory pathway conduction was not present (42 patients). Transmural cryoablation was used under normothermic cardiopulmonary bypass when accessory pathway conduction persisted after dissection (subendocardial pathway). In all, cardiopulmonary bypass was not used in 41 patients. There was one early relapse that required transmural cryoablation. There were no complications.
Collapse
|
46
|
Zardini M, Leitch JW, Guiraudon GM, Klein GJ, Yee R. Atrioventricular nodal reentry and dual atrioventricular node physiology in patients undergoing accessory pathway ablation. Am J Cardiol 1990; 66:1388-9. [PMID: 2244577 DOI: 10.1016/0002-9149(90)91178-9] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- M Zardini
- Department of Surgery, University Hospital, London, Ontario, Canada
| | | | | | | | | |
Collapse
|
47
|
Yee R, Klein GJ, Guiraudon GM, Jones DL, Sharma AD, Norris C. Initial clinical experience with the pacemaker-cardioverter-defibrillator. Can J Cardiol 1990; 6:147-56. [PMID: 2344560] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
The implantation of a new multiprogrammable pacemaker-cardioverter-defibrillator is reported in four patients suffering from drug-refractory ventricular tachycardia or fibrillation. The generator (PCD 7215; Medtronic Inc) was interfaced to the epicardium by three countershock patch electrodes and one ventricular myocardial screw-in lead for sensing/pacing. The device employs separate rate detection criteria for ventricular tachycardia and ventricular fibrillation with automatic delivery of up to four therapies per episode. Therapeutic options include: antitachycardia burst or autodecremental pacing, synchronized cardioversion, defibrillation and ventricular demand pacing at 30 to 90 beats/min. Four men and one woman (ages 29 to 75 years) underwent intraoperative implant evaluation, and the device was implanted in the four men. Over a follow-up of 1.5 to 23 months, 161 spontaneous episodes of ventricular tachycardia and nine episodes meeting ventricular fibrillation criteria (cycle length less than 280 to 290 ms) were detected and treated by the device. Ramp pacing was initially employed to terminate 140 ventricular tachycardia episodes and was successful 88.5% of the time while 10 (7.2%) required low energy epicardial cardioversion (4 to 10 J). Six (4.3%) episodes terminated spontaneously prior to therapy delivery. All nine spontaneous episodes of ventricular fibrillation were defibrillated using 10 to 15 J. Two patients continue to do well with the device functioning reliably. The device was removed at the time of heart transplant in one patient, while another patient died suddenly from drug overdose. No other complications, device malfunctions or inappropriate therapy delivery have been observed. These early results demonstrate the potential usefulness of a programmable device which provides graded therapy for ventricular tachycardia with added defibrillation and bradycardia pacing capability.
Collapse
Affiliation(s)
- R Yee
- Department of Medicine, University Hospital, London, Ontario
| | | | | | | | | | | |
Collapse
|
48
|
Guiraudon GM, Klein GJ, Sharma AD, Yee R, Kaushik RR, Fujimura O. Skeletonization of the atrioventricular node for AV node reentrant tachycardia: experience with 32 patients. Ann Thorac Surg 1990; 49:565-72; discussion 572-3. [PMID: 2322051 DOI: 10.1016/0003-4975(90)90302-m] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
We describe our experience with operative therapy for atrioventricular (AV) node tachycardia using an anatomically guided procedure. The operative rationale was to dissect the AV node from most of its atrial inputs (AV node "skeletonization") with the intent of altering the perinodal substrate and preventing reentry. The anteroseptal and posteroseptal regions were initially approached epicardially to facilitate identification of anatomical structures. Under normothermic cardiopulmonary bypass, the right atrial septum was mobilized and the intermediate AV node was exposed anterior to the tendon of Todaro. Atrioventricular node conduction was monitored electrocardiographically throughout the procedure. Ablation of concomitant accessory pathways was done prior to AV node skeletonization. Thirty-two patients aged 9 to 67 years (mean age, 30 years) underwent operation. Five patients had concomitant accessory pathways in addition to AV node reentry. At electrophysiological study before discharge, no patient had AV block although anterograde and retrograde Wenckebach cycle lengths were significantly prolonged. Six patients had retrograde AV block. Twenty-nine patients are free from arrhythmia and require no antiarrhythmic medication after a follow-up of 1 month to 45 months (mean follow-up, 17 months). Three patients had recurrence of tachycardia ten days, 2 months, and 7 months postoperatively. All patients subsequently had a successful reoperation.
Collapse
Affiliation(s)
- G M Guiraudon
- Department of Surgery, University of Western Ontario, University Hospital, London, Canada
| | | | | | | | | | | |
Collapse
|
49
|
Dobkowski WB, Murkin JM, Sharpe MD, Sharma AD, Yee R, Guiraudon GM. THE EFFECT OF ISOFLURANE (1MAC) ON THE NORMAL AV CONDUCTION SYSTEM AND ACCESSORY PATHWAYS. Anesth Analg 1990. [DOI: 10.1213/00000539-199002001-00086] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
50
|
Guiraudon GM, Klein GJ, van Hemel N, Guiraudon CM, Yee R, Vermeulen FE. Anatomically guided surgery to the AV node. AV nodal skeletonization: experience in 46 patients with AV nodal reentrant tachycardia. Eur J Cardiothorac Surg 1990; 4:461-4; discussion 464-5. [PMID: 2223125 DOI: 10.1016/1010-7940(90)90166-w] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
We report our combined experience with operative therapy for atrioventricular nodal tachycardia using an anatomically guided procedure. The operative rationale was to dissect the AV node with the intent of modifying perinodal tissues (skeletonization). The anterior septal and posterior septal regions were initially approached epicardially to facilitate endocardial dissection. Under normothermic cardiopulmonary bypass, the right atrial septum was mobilized and the intermediate AV node was exposed anterior to the tendon of Todaro. Ablation of concomitant accessory pathways was done prior to AV nodal skeletonization. Forty-six patients aged 9-71 years (mean 36) were operated upon. Five patients had accessory pathways in addition to AV nodal reentry. At electro-physiological study prior to discharge, no patient had an AV block although anterograde and retrograde Wenckebach cycle lengths were significantly prolonged. Ten patients had a retrograde AV block. The 46 patients were free of arrhythmia and not taking antiarrhythmic medication after a follow-up of 1-45 months (mean 17). Three patients had a recurrence of the tachycardia 10 days, 2 months and 7 months post-operatively, respectively. All patients had a subsequently successful reoperation.
Collapse
Affiliation(s)
- G M Guiraudon
- Department of Surgery, University of Western Ontario, University Hospital, London, Canada
| | | | | | | | | | | |
Collapse
|